Connection

THOMAS MONATH to Immunoglobulin G

This is a "connection" page, showing publications THOMAS MONATH has written about Immunoglobulin G.
Connection Strength

0.361
  1. Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Infect Immun. 2003 Mar; 71(3):1608-10.
    View in: PubMed
    Score: 0.042
  2. Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun. 2001 Feb; 69(2):988-95.
    View in: PubMed
    Score: 0.036
  3. Intranasal antibody prophylaxis for protection against viral disease. Clin Microbiol Rev. 1999 Jul; 12(3):383-93.
    View in: PubMed
    Score: 0.033
  4. Serologic IgG response to urease in Helicobacter pylori-infected persons from Mexico. Am J Trop Med Hyg. 1999 Apr; 60(4):587-92.
    View in: PubMed
    Score: 0.032
  5. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. CMAJ. 2017 Jun 19; 189(24):E819-E827.
    View in: PubMed
    Score: 0.028
  6. Safety and immunogenicity of the rVSV?G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study. Lancet Infect Dis. 2017 08; 17(8):854-866.
    View in: PubMed
    Score: 0.028
  7. Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate. Dig Dis Sci. 1996 Sep; 41(9):1853-62.
    View in: PubMed
    Score: 0.027
  8. Antigenicity of amino-acid sequences from Clostridium difficile toxin B. J Med Microbiol. 1996 Jun; 44(6):464-74.
    View in: PubMed
    Score: 0.026
  9. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis. 1995 Jul; 172(1):161-72.
    View in: PubMed
    Score: 0.025
  10. Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice. Antimicrob Agents Chemother. 1994 Dec; 38(12):2785-91.
    View in: PubMed
    Score: 0.024
  11. Specific immunoglobulin A antibodies in maternal milk and delayed Helicobacter pylori colonization in Gambian infants. Clin Infect Dis. 2004 Oct 15; 39(8):1155-60.
    View in: PubMed
    Score: 0.012
  12. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori. Vaccine. 2002 Dec 13; 21(3-4):194-201.
    View in: PubMed
    Score: 0.010
  13. Fluorescent antibody techniques applied to the identification of dengue virus in infected tissue. Acta Virol. 1982 Sep; 26(5):376-81.
    View in: PubMed
    Score: 0.010
  14. Indirect fluorescent antibody test for the diagnosis of yellow fever. Trans R Soc Trop Med Hyg. 1981; 75(2):282-6.
    View in: PubMed
    Score: 0.009
  15. Risk of Helicobacter pylori infection among long-term residents in developing countries. Am J Trop Med Hyg. 1999 Feb; 60(2):267-70.
    View in: PubMed
    Score: 0.008
  16. Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol. 1995 May; 2(3):302-6.
    View in: PubMed
    Score: 0.006
  17. Comparison of methods for removal of nonspecific inhibitors of arbovirus hemagglutination. Appl Microbiol. 1970 Nov; 20(5):748-53.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.